Rosetta Genomics Ltd. - Ordinar ROSG
Set alert
At close · Jun 28
- YTD
- -100.00%
- 1 year
- -100.00%
- Open
- 0.43
- Prev close
- 0.43
- Mkt cap
- 2.07M
- Vol
- 169.60K
- Avg vol
- 104.81K
- EPS
- -6.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.42
- High
- 0.44
- Forward P/E
- -0.09
- Beta
- 0.64
- Short ratio
- 1.54
- Inst. own
- 14.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.398
- 200-d avg
- 0.594118
- 1y target
- 24.00
News
10 years ago businesswire.com
Rosetta Genomics to Host 2016 Second Quarter Financial Results and Business Update Conference Call on September 26, 2016
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today announced that the…
10 years ago businesswire.com
Rosetta Genomics to Host 2016 First Quarter Financial Results and Business Update Conference Call on May 19, 2016
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today announced that the…
10 years ago businesswire.com
Rosetta Genomics to Host Business Update and 2015 Year-End Financial Results Conference Call on March 23, 2016
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today announced that…
11 years ago businesswire.com
Rosetta Genomics to Host Business Update and Six Month Financials Conference Call on October 27, 2015
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today announced that…
11 years ago businesswire.com
Rosetta Genomics to Host Business Update and 2014 Year End Financials Conference Call on March 17, 2015
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that following the…